These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8255914)

  • 21. Pharmacological characterization of PD 118717, a putative piperazinyl benzopyranone dopamine autoreceptor agonist.
    Pugsley TA; Christofferson CL; Corbin A; DeWald HA; Demattos S; Meltzer LT; Myers SL; Shih YH; Whetzel SZ; Wiley JN
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1147-58. PubMed ID: 1361570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy.
    Eskow KL; Gupta V; Alam S; Park JY; Bishop C
    Pharmacol Biochem Behav; 2007; 87(3):306-14. PubMed ID: 17553556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behavioural effects induced in rats and chicks by D2 dopamine agonists.
    Ferrari F; Giuliani D
    Physiol Behav; 1993 Oct; 54(4):695-700. PubMed ID: 7902587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
    Costall B; Domeney AM; Naylor RJ; Tyers MB
    Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence concerning the involvement of 5-hydroxytryptamine in the locomotor activity produced by amphetamine or tranylcypromine plus L-DOPA.
    Green AR; Kelly PH
    Br J Pharmacol; 1976 May; 57(1):141-7. PubMed ID: 1276533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of local application of 5-HT and 8-OH-DPAT into the dorsal and median raphe nuclei on motor activity in the rat.
    Hillegaart V
    Physiol Behav; 1990 Jul; 48(1):143-8. PubMed ID: 2146690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of intraventricular administration of norepinephrine, dopamine and 5-hydroxytryptamine on motor activity of rats.
    Kulkarni SK; Dandiya PC
    Indian J Med Res; 1975 Mar; 63(3):462-8. PubMed ID: 1213741
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of LSD on prepulse inhibition and spontaneous behavior in the rat. A pharmacological analysis and comparison between two rat strains.
    Ouagazzal A; Grottick AJ; Moreau J; Higgins GA
    Neuropsychopharmacology; 2001 Oct; 25(4):565-75. PubMed ID: 11557170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. L-DOPA-induced behavioral sensitization of motor activity in the MPTP-treated common marmoset as a Parkinson's disease model.
    Ando K; Inoue T; Itoh T
    Pharmacol Biochem Behav; 2014 Dec; 127():62-9. PubMed ID: 25449794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats.
    Deakin JF; Green AR
    Br J Pharmacol; 1978 Oct; 64(2):201-9. PubMed ID: 708990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates, the selective 5-hydroxytryptamine 1a agonist (R)-(+)-8-OHDPAT inhibits levodopa-induced dyskinesia but only with\ increased motor disability.
    Iravani MM; Tayarani-Binazir K; Chu WB; Jackson MJ; Jenner P
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1225-34. PubMed ID: 16959959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and evaluation of pharmacological and pharmacokinetic properties of monopropyl analogs of 5-, 7-, and 8-[[(trifluoromethyl)sulfonyl]oxy]-2-aminotetralins: central dopamine and serotonin receptor activity.
    Sonesson C; Barf T; Nilsson J; Dijkstra D; Carlsson A; Svensson K; Smith MW; Martin IJ; Duncan JN; King LJ
    J Med Chem; 1995 Apr; 38(8):1319-29. PubMed ID: 7731017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 5-HT syndrome and the drug discrimination paradigm in rats: application in behavioral studies on the central 5-HT system.
    Ortmann R
    Pharmacopsychiatry; 1985 Mar; 18(2):198-201. PubMed ID: 3875109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidepressant treatments: effects in rodents on dose-response curves of 5-hydroxytryptamine- and dopamine-mediated behaviours and 5-HT2 receptor number in frontal cortex.
    Green AR; Heal DJ; Johnson P; Laurence BE; Nimgaonkar VL
    Br J Pharmacol; 1983 Oct; 80(2):377-85. PubMed ID: 6606460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of 5-hydroxytryptamine given IVC on rat behaviour.
    Drybański Z
    Pol J Pharmacol Pharm; 1975 Oct; 27(Suppl):83-8. PubMed ID: 1208232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the thermoregulatory responses to intracerebroventricularly injected dopamine, noradrenaline and 5-hydroxytryptamine in the goat.
    De Roij TO; Frens J; Woutersen-Van-Nijnanten F; Vianen-Meijerink M
    Eur J Pharmacol; 1978 Jun; 49(4):395-405. PubMed ID: 668811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
    Green AR; Youdim MB
    Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ; Gobert A; Newman-Tancredi A; Audinot V; Lejeune F; Rivet JM; Cussac D; Nicolas JP; Muller O; Lavielle G
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1341-55. PubMed ID: 9732398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Facilitation of amphetamine-induced hypothermia in mice by GABA agonists and CCK-8.
    Boschi G; Launay N; Rips R
    Br J Pharmacol; 1991 Apr; 102(4):986-90. PubMed ID: 1855128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.